| |
| |
|
| Insider
Information: |
Zinda Michael |
| Relationship: |
|
| City: |
St-Laurent |
| State: |
A8 |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
71,908 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
71,908 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Repare Therapeutics Inc. |
RPTX |
|
2024-04-01 |
71,908 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| RPTX |
Repare Therapeutics Inc. |
EVP, CHIEF SCIENTIFIC OFFICER |
• – – |
2024-04-01 |
4 |
AS |
$4.66 |
$1,911 |
D/D |
(410) |
71,908 |
0 |
- |
|
| RPTX |
Repare Therapeutics Inc. |
EVP, CHIEF SCIENTIFIC OFFICER |
• – – |
2024-03-28 |
4 |
AS |
$4.64 |
$2,088 |
D/D |
(450) |
72,318 |
0 |
- |
|
| RPTX |
Repare Therapeutics Inc. |
EVP, CHIEF SCIENTIFIC OFFICER |
• – – |
2024-03-27 |
4 |
AS |
$4.62 |
$2,079 |
D/D |
(450) |
72,768 |
0 |
- |
|
| RPTX |
Repare Therapeutics Inc. |
EVP, CHIEF SCIENTIFIC OFFICER |
• – – |
2024-03-26 |
4 |
AS |
$4.61 |
$2,075 |
D/D |
(450) |
73,218 |
0 |
- |
|
| RPTX |
Repare Therapeutics Inc. |
EVP, CHIEF SCIENTIFIC OFFICER |
• – – |
2024-03-25 |
4 |
AS |
$4.78 |
$2,151 |
D/D |
(450) |
73,668 |
0 |
- |
|
| RPTX |
Repare Therapeutics Inc. |
EVP, CHIEF SCIENTIFIC OFFICER |
• – – |
2024-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
14,000 |
74,118 |
0 |
- |
|
| RPTX |
Repare Therapeutics Inc. |
EVP, Chief Scientific Officer |
• – – |
2023-06-08 |
4 |
S |
$12.02 |
$34,485 |
D/D |
(2,869) |
60,118 |
0 |
- |
|
| RPTX |
Repare Therapeutics Inc. |
EVP, Chief Scientific Officer |
• – – |
2023-06-07 |
4 |
AS |
$12.03 |
$77,040 |
D/D |
(6,404) |
62,987 |
0 |
- |
|
| RPTX |
Repare Therapeutics Inc. |
EVP, Chief Scientific Officer |
• – – |
2023-06-06 |
4 |
AS |
$12.04 |
$14,448 |
D/D |
(1,200) |
69,391 |
0 |
- |
|
| RPTX |
Repare Therapeutics Inc. |
EVP, Chief Scientific Officer |
• – – |
2023-01-30 |
4 |
A |
$0.00 |
$0 |
D/D |
24,550 |
70,591 |
0 |
- |
|
| RPTX |
Repare Therapeutics Inc. |
EVP, Chief Science Officer |
• – – |
2022-03-15 |
4 |
AS |
$11.30 |
$6,023 |
D/D |
(533) |
46,041 |
0 |
- |
|
| RPTX |
Repare Therapeutics Inc. |
EVP, Chief Science Officer |
• – – |
2021-11-23 |
4 |
OE |
$1.64 |
$91,948 |
D/D |
46,041 |
46,574 |
0 |
- |
|
| RPTX |
Repare Therapeutics Inc. |
EVP, Chief Science Officer |
• – – |
2021-11-15 |
4 |
AS |
$27.20 |
$546,613 |
D/D |
(20,000) |
533 |
0 |
- |
|
| RPTX |
Repare Therapeutics Inc. |
EVP, Chief Science Officer |
• – – |
2021-08-16 |
4 |
AS |
$33.97 |
$509,886 |
D/D |
(15,000) |
20,533 |
0 |
- |
|
| RPTX |
Repare Therapeutics Inc. |
EVP, Chief Science Officer |
• – – |
2021-05-17 |
4 |
AS |
$31.65 |
$490,710 |
D/D |
(15,000) |
35,533 |
0 |
- |
|
| RPTX |
Repare Therapeutics Inc. |
EVP, Chief Science Officer |
• – – |
2020-12-29 |
4 |
S |
$33.30 |
$663,097 |
D/D |
(19,696) |
50,533 |
0 |
- |
|
| RPTX |
Repare Therapeutics Inc. |
EVP, Chief Science Officer |
• – – |
2020-12-28 |
4 |
S |
$34.24 |
$515,359 |
D/D |
(15,048) |
70,229 |
0 |
- |
|
| RPTX |
Repare Therapeutics Inc. |
EVP, Chief Science Officer |
• – – |
2020-12-28 |
4 |
OE |
$2.06 |
$99 |
D/D |
48 |
85,277 |
0 |
- |
|
| RPTX |
Repare Therapeutics Inc. |
EVP, Chief Science Officer |
• – – |
2020-12-24 |
4 |
S |
$33.14 |
$14,316 |
D/D |
(432) |
85,229 |
0 |
- |
|
| RPTX |
Repare Therapeutics Inc. |
EVP, Chief Science Officer |
• – – |
2020-12-24 |
4 |
OE |
$2.06 |
$891 |
D/D |
432 |
85,661 |
0 |
- |
|
| RPTX |
Repare Therapeutics Inc. |
EVP, Chief Science Officer |
• – – |
2020-12-23 |
4 |
S |
$33.48 |
$546,417 |
D/D |
(16,235) |
85,229 |
0 |
- |
|
| RPTX |
Repare Therapeutics Inc. |
EVP, Chief Science Officer |
• – – |
2020-12-23 |
4 |
OE |
$1.64 |
$36,081 |
D/D |
16,235 |
101,464 |
0 |
- |
|
| RPTX |
Repare Therapeutics Inc. |
EVP, Chief Science Officer |
• – – |
2020-12-22 |
4 |
OE |
$1.64 |
$78,510 |
D/D |
41,312 |
126,541 |
0 |
- |
|
| RPTX |
Repare Therapeutics Inc. |
EVP, Chief Science Officer |
• – – |
2020-12-22 |
4 |
S |
$33.36 |
$1,379,200 |
D/D |
(41,312) |
85,229 |
0 |
- |
|
| RPTX |
Repare Therapeutics Inc. |
EVP, Chief Science Officer |
• – – |
2020-12-21 |
4 |
S |
$33.08 |
$1,323,200 |
D/D |
(40,000) |
85,229 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
